Reports for ALLERGAN INC

Company Name

ALLERGAN INC

Totals

Shortage reports

30

Actual shortage: 3 (10%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 27 (90%)

Discontinuation Reports

2

To be discontinued: 0 (0%)
Discontinued: 2 (100%)
Reversed: 0 (0%)

Late reports

6 (19%)

Overdue reports

1 (33%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
LUMIGAN 0.03% SOLUTION Actual shortage 2017-04-05 2017-10-05 5736
TAZORAC 0.05% GEL Resolved 2018-11-01 2019-05-18 65978
TAZORAC 0.05% CREAM Resolved 2018-11-02 2018-12-01 66116
RESTASIS MULTIDOSE 0.05% EMULSION Actual shortage 2019-02-01 2019-02-01 74356
TAZORAC 0.1% GEL Resolved 2018-11-02 2018-12-01 66125
ALPHAGAN P 0.15% SOLUTION Resolved 2019-01-21 2019-01-23 73016
BLEPHAMIDE OPHT SUSPENSION 0.2% 10% DROPS Resolved 2018-02-19 2018-04-21 40184
BLEPHAMIDE OPHT SUSPENSION 0.2% 10% DROPS Resolved 2018-02-19 2018-04-21 40187
BLEPHAMIDE OPHT SUSPENSION 0.2% 10% DROPS Resolved 2019-03-03 2019-04-15 77338
BLEPHAMIDE OPHT SUSPENSION 0.2% 10% DROPS Resolved 2019-03-03 2019-04-19 77342
BLEPHAMIDE OPH ONT 0.2% 10% OINTMENT Actual shortage 2018-02-19 2018-04-20 40190
BETAGAN OPH SOLN 0.25% 0.25% LIQUID Resolved 2017-04-06 2017-08-04 5781
ZYMAR 0.3% SOLUTION Resolved 2017-08-03 2017-10-13 18241
ACUVAIL 0.45% SOLUTION Resolved 2018-10-09 2018-10-19 63456
ACUVAIL 0.45% SOLUTION Resolved 2019-03-20 2019-04-26 78953
ACULAR LIQ 0.5% 0.5% SOLUTION Resolved 2018-11-06 2019-02-21 66328
ACULAR LIQ 0.5% 0.5% SOLUTION Resolved 2019-02-15 2019-03-15 75873
OZURDEX 0.7MG IMPLANT Resolved 2019-02-21 2019-03-21 76570
OZURDEX 0.7MG IMPLANT Resolved 2019-04-08 2019-04-27 80819
BYSTOLIC 10.0MG TABLET Resolved 2019-01-29 2019-02-22 73787

Showing 1 to 20 of 30

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
BETAGAN OPH SOLN 0.25% 0.25% LIQUID Discontinued 2017-08-04 2017-08-04 18275
ALOCRIL 2% LIQUID Discontinued 2018-11-28 2019-04-02 67803